Skip to main content

Table 2 The genetically engineered mouse models of hepatocellular carcinoma

From: An overview of mouse models of hepatocellular carcinoma

Author

Model

Technology

Mouse strains

Method

Xue et al. [43]

HCC

Sleeping beauty CRISPR-Cas9 system

FVB

Hydrodynamic injection of a CRISPR plasmid DNA expressing Cas9 and sgRNAs to the liver and directly target the tumor suppressor genes Pten and p53, alone and in combination.

Bell et al. [44]

HCC

Sleeping beauty transposon system

C57BL/6

The rapid, high-pressure injection of a naked plasmid DNA solution (2ml DNA/20 g mouse) into the tail vein within a period of 4 − 7 s.

Katz et al. [47]

HCC

Cre-loxp

C57BL/6

Conditional Trp53F2–10/F2–10 KO mice were crossed with AFP-cre mice.

Calvisi et al. [48]

HCC

Cre-loxp

C57

TG mice were generated by crossing homozygous c-Myc with homozygous E2F1 mice.

Tward et al. [49]

HCC

Sleeping beauty transposon system

FVB/N

Ten to 50 micrograms of the plasmids encoding the Sleeping Beauty transposase and transposons with oncogenes of interest in a ratio of 1:25 were diluted in 2.5 ml of filtered 0.9% NaCl and then injected into the lateral tail veins of 6- to 8-week-old mice.

Cao et al. [50]

HCC

CRISPR-Cas9 and sleeping beauty transposon system

C57BL/6

Plasmids pCMV/SB, PT3-EF1a-c-Met, PT3-△90-β-catenin, Lenti CRISPR-sgPten and LentiCRISPR-sgp53 were injected into mice at a dosage of 10 µg/mouse within 3–5 s/time.

Ochiai et al. [51]

HCC

Cre-loxp

C57BL/6

Conditional TFF1 KO mice were crossed with Alb-cre mice to generate a TFF1-deficient HCC mouse model (KC/TFF1−/−).

Kenerson et al. [53]

HCC

Cre-loxp

C57BL/6

Tsc1f/f and Ptenf/f mice were separately bred with Alb-cre mice to generate Tsc1f/f; Alb-cre and Ptenf/f; Alb-cre mice respectively. Double knockout mutant mice (Tsc1f/f; Ptenf/f;Alb-cre) were created by crossing Tsc1f/f;Alb-cre with Ptenf/f; Alb-cre mice to generate Tsc1f/+;Ptenf/+;Alb-cre mice.

Sekine et al. [54]

HCC

Cre-loxp

C57

Conditional Ctnnb1 KO mice were crossed with Alb-cre mice to generate an Alb-cre; Ctnnb1f/f mouse model, which developed hepatocellular adenomas and carcinomas at age of 1 year.

Zheng et al. [55]

HCC

Cre-loxp

C57BL/6

We crossed CAG-loxp-LacZ T antigen mice with Alb-cre mice, and observed HCC at 3–10 months of age.

Ruiz et al. [58]

HCC

CRISPR-Cas9 system

C57BL/6

Hydrodynamic injection of px330-sg-p53 and CMV-SB13 in combination with MYC-luc or MYC-lucOS into 6-week-old female mice. The majority of MYC-luc; sg-p53 mice presented gross liver tumors that caused death with a median survival of 35–44 days.

  1. Note: HCC, hepatocellular carcinoma; TG, transgene; KO, knockout